Screening for heart disease in diabetic subjects

American Heart Journal

Volumn 149, Issue 2, 2005, Pages 349-354

  Fang, Zhi You ^a   Schull Meade, Rebecca ^a   Leano, Rodel ^a   Mottram, Philip M ^a   Prins, Johannes B ^a   Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLE; EXERCISE TEST; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; SYSTOLE; VELOCITY;

EID: 14844331063     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.06.021     Document Type: Article

References (33)

1. Self-reported heart disease and stroke among adults with and without diabetes-United States, 1999-2001 MMWR Morb. Mortal. Wkly. Rep. 52 2003 1065 1070
2. Z.Y. Fang, R. Leano, and T.H. Marwick Relationship between longitudinal and radial contractility in subclinical diabetic heart disease Clin. Sci. (Lond) 106 2004 53 60
3. N.H. Andersen, S.H. Poulsen, and H. Eiskjaer Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study Clin. Sci. (Lond) 105 2003 59 66
4. Z.Y. Fang, O. Najos-Valencia, and R. Leano Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine J. Am. Coll. Cardiol. 42 2003 446 453
5. D. Vinereanu, E. Nicolaides, and A.C. Tweddel Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin Clin. Sci. (Lond) 105 2003 591 599
6. Y. Murakami, T. Shimada, and S. Inoue New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy Can. J. Cardiol. 18 2002 1294 1300
7. J.P. Goetze, C. Christoffersen, and M. Perko Increased cardiac BNP expression associated with myocardial ischemia FASEB J. 17 2003 1105 1107
8. R.B. Devereux, and N. Reichek Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method Circulation 55 1977 613 618
9. D. Levy, D.D. Savage, and R.J. Garrison Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study Am. J. Cardiol. 59 1987 956 960
10. N.P. Nikitin, K.K. Witte, and S.D. Thackray Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging J. Am. Soc. Echocardiogr. 16 2003 906 921
11. M. Vogeser, and K. Jacob B-type natriuretic peptide (BNP)-validation of an immediate response assay Clin. Lab. 47 2001 29 33
12. M.M. Redfield, R.J. Rodeheffer, and S.J. Jacobsen Plasma brain natriuretic peptide concentration: impact of age and gender J. Am. Coll. Cardiol. 40 2002 976 982
13. A. Dawson, and A.D. Struthers Screening for treatable left ventricular abnormalities in diabetic patients Expert. Opin. Biol. Ther. 3 2003 107 112
14. P. Almeida, A. Azevedo, and R. Rodrigues B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients Rev. Port. Cardiol. 22 2003 327 336
15. R.S. Vasan, E.J. Benjamin, and M.G. Larson Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study JAMA 288 2002 1252 1259
16. M. Nakamura, F. Tanaka, and S. Yonezawa The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients Am. J. Hypertens. 16 2003 1025 1029
17. V.H. Casco, J.P. Veinot, and M.L. Kuroski de Bold Natriuretic peptide system gene expression in human coronary arteries J. Histochem. Cytochem. 50 2002 799 809
18. M. Arad, E. Elazar, and A. Shotan Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure Cardiology 87 1996 12 17
19. J. Tateishi, M. Masutani, and M. Ohyanagi Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty Clin. Cardiol. 23 2000 776 780
20. K. Kikuta, H. Yasue, and M. Yoshimura Increased plasma levels of B-type natriuretic peptide in patients with unstable angina Am. Heart J. 132 1996 101 107
21. S. Nicholson, M. Richards, and E. Espiner Atrial and brain natriuretic peptide response to exercise in patients with ischaemic heart disease Clin. Exp. Pharmacol. Physiol. 20 1993 535 540
22. T. Tsutamoto, A. Wada, and K. Maeda Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1 Eur. Heart J. 20 1999 1799 1807
23. A.S. Maisel, J. Koon, and P. Krishnaswamy Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction Am. Heart J. 141 2001 367 374
24. K. Mori, T. Manabe, and M. Nii Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy Pediatr. Cardiol. 23 2002 160 166
25. M. Bayerle-Eder, M. Zangeneh, and G. Kreiner ANP but not BNP reflects early left diastolic dysfunction in type 1 diabetics with myocardial dysinnervation Horm. Metab. Res. 35 2003 301 307
26. K. Bibbins-Domingo, M. Ansari, and N.B. Schiller Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study Am. J. Med. 116 2004 509 516
27. M.M. Redfield, R.J. Rodeheffer, and S.J. Jacobsen Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction. A community-based study Circulation 109 2004 3176 3181
28. A. Tanabe, M. Naruse, and T. Wasada Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations Eur. J. Endocrinol. 132 1995 693 698
29. K. McKenna, D. Smith, and W. Tormey Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in type 1 diabetes mellitus Diabet. Med. 17 2000 512 517
30. C. Christoffersen, J.P. Goetze, and E.D. Bartels Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart Hypertension 40 2002 54 60
31. M. Inoue, T. Kanda, and M. Arai Impaired expression of brain natriuretic peptide gene in diabetic rats with myocardial infarction Exp. Clin. Endocrinol. Diabetes 106 1998 484 488
32. T.J. Wang, M.G. Larson, and D. Levy Impact of obesity on plasma natriuretic peptide levels Circulation 109 2004 594 600
33. M.R. Mehra, P.A. Uber, and M.H. Park Obesity and suppressed B-type natriuretic peptide levels in heart failure J Am. Coll. Cardiol. 43 2004 1590 1595